The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

“This is a really exciting new area that has tremendous potential to assist drug discovery and development,” says Koguchi. “It’s creating new avenues of research that were never before ...

In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a ...

Traditionally, hybridoma technology — a five-step process based on the fusion ... including antibody drug development. The single cells flow one by one in the droplets, while the testing and ...